secwatch / observer
8-K filed February 7, 2024, 6:59 PM ET CIK 0001008586
debt confidence high sentiment neutral materiality 0.70

STREAMLINE HEALTH SOLUTIONS INC.: debt financing — Streamline Health raises ~$4.5M, modifies credit facility, appoints two directors

STREAMLINE HEALTH SOLUTIONS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matthew Etheridge

Director
STREAMLINE HEALTH SOLUTIONS INC.
Effective
2024-02-07
Filed
February 7, 2024, 6:59 PM ET
appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.
Appointed

Benjamin L. Stilwill

Director
STREAMLINE HEALTH SOLUTIONS INC.
Effective
2024-02-07
Filed
February 7, 2024, 6:59 PM ET
appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

STREAMLINE HEALTH SOLUTIONS INC. amended credit facility with Western Alliance Bank.

Instrument
credit facility
Counterparty
Western Alliance Bank
Event
amendment
Exact text from the filing
On February 7, 2024, the Company and certain of its subsidiaries entered into a Third Modification and Waiver (the “Third Modification”) to Second Amended and Restated Loan and Security Agreement (the “Loan and Security Agreement”) with WAB.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Etheridge was appointed as Director at STREAMLINE HEALTH SOLUTIONS INC..

Action
appointed
Role
Director
Exact text from the filing
appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Benjamin L. Stilwill was appointed as Director at STREAMLINE HEALTH SOLUTIONS INC..

Action
appointed
Role
Director
Exact text from the filing
appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private Placement on February 7, 2024.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

STREAMLINE HEALTH SOLUTIONS INC. entered into Securities Purchase Agreement with certain accredited investors, including certain directors and officers of the Company (collectively, the "Investors") valued at aggregate principal amount of $4.4 million (effective 2024-02-01).

Action
entry
Agreement
equity purchase
Counterparty
certain accredited investors, including certain directors and officers of the Company (collectively, the "Investors")
Value
aggregate principal amount of $4.4 million
Effective
2024-02-01
Exact text from the filing
On February 1, 2024, Streamline Health Solutions, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain accredited investors, including certain directors and officers of the Company (collectively, the “Investors”), pursuant to which the Company agreed to sell to the Investors unsecured subordinated promissory notes (the “Notes”) in the aggregate principal amount of $4.4 million and warrants
View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR
accession 0001493152-24-005268
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.